Abeona Therapeutics Inc. (ABEO) earnings
ABEO earnings moved a median of +5.55% by the close. Quarterly and annual ABEO reports and results, each read against the price at its own news timestamp. Back to the ABEO overview →
22 measured ABEO earnings events.
Where these ABEO earnings landedvs 22 measured ABEO earnings reactions
| Middle 50% of ABEO earnings reactions | -1.40% to +8.33% |
|---|---|
| Median reaction (to close) | +5.55% |
| Measured reactions | 22 |
Point-in-time · zero look-ahead
Half of the 22 ABEO earnings events with a measured close landed between -1.40% and +8.33%; 68% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update | Press release | +5.91% | +4.19% | |
| Form 10-Q ABEONA THERAPEUTICS INC. For: Jun 30 | SEC filing · Form 10-Q | +5.91% | +4.19% | |
| Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026 | Press release | +2.06% | +1.77% | |
| Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update | Press release | -1.29% | -1.72% | |
| Form 10-Q ABEONA THERAPEUTICS INC. For: Mar 31 | SEC filing · Form 10-Q | -1.29% | -1.72% | |
| Form 10-K ABEONA THERAPEUTICS INC. For: Dec 31 | SEC filing · Form 10-K | -4.39% | -0.42% | |
| Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates | Press release | +10.00% | +7.39% | |
| Form 10-Q ABEONA THERAPEUTICS INC. For: Sep 30 | SEC filing · Form 10-Q | +10.00% | +7.39% | |
| Abeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate Updates | Press release | +0.58% | +5.55% | |
| Form 10-Q ABEONA THERAPEUTICS INC. For: Jun 30 | SEC filing · Form 10-Q | +0.58% | +5.55% | |
| Abeona Therapeutics® Reports First Quarter 2025 Financial Results and Corporate Updates | Press release | +1.49% | +8.02% | |
| Form 10-Q ABEONA THERAPEUTICS INC. For: Mar 31 | SEC filing · Form 10-Q | +1.49% | +8.02% | |
| Form 10-K ABEONA THERAPEUTICS INC. For: Dec 31 | SEC filing · Form 10-K | -0.84% | -4.10% | |
| Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates | Press release | -5.08% | -5.56% | |
| Form 10-Q ABEONA THERAPEUTICS INC. For: Sep 30 | SEC filing · Form 10-Q | -5.08% | -5.56% | |
| Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission | Press release | +0.00% | +10.00% | |
| Form 10-Q ABEONA THERAPEUTICS INC. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +10.00% | |
| Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress | Press release | +5.66% | +11.09% | |
| Form 10-Q ABEONA THERAPEUTICS INC. For: Mar 31 | SEC filing · Form 10-Q | +5.66% | +11.09% | |
| Form 10-K ABEONA THERAPEUTICS INC. For: Dec 31 | SEC filing · Form 10-K | -9.39% | -11.07% | |
| Abeona Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Developments | Press release | -2.22% | +8.43% | |
| Form 10-Q ABEONA THERAPEUTICS INC. For: Sep 30 | SEC filing · Form 10-Q | -2.22% | +8.43% |
Keep exploring
More ABEO: analyst actions → · SEC filings → · ABEO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Veracyte, Inc. (VCYT) | 414 | -0.24% | 42% |
| Verastem, Inc. (VSTM) | 414 | -0.11% | 48% |
| Align Technology, Inc. (ALGN) | 411 | -0.02% | 48% |
| EyePoint, Inc. (EYPT) | 409 | -0.24% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.